Table 1.
Demographic characteristics of study subjectsa.
| Prevalent Liver Disease Cohort | HIV seroconverter Cohort | HCV seroconverter Cohort | ||
|---|---|---|---|---|
| Cirrhosis | Minimal disease | |||
| Total number | 17 | 71 | 29 | 34 |
| Mean age (years±SD) | 50.5 ± 6.2 | 41.7 ± 6.0 | 35.8 ± 6.4 | 24.4 ± 3.0 |
| Gender, male (%) | 10 (58.8) | 60 (84.5) | 19 (65.5) | 21 (61.7) |
| Race, black (%) | 16 (94.1) | 69 (97.2) | 28 (96.6) | 5 (14.7) |
| HIV (%) | 8 (47.1) | 20 (28.2) | 29 (100) | 0 (0)b |
| Proportion injecting illicit drugs (in prior 6 mo) | 7 (41.2) | 39 (54.9) | 26 (89.7) | 100% |
| Alcohol use | ||||
| None | 11 (64.7) | 26 (36.6) | 2 (7.1) | not available |
| >1 drink/day | 5 (29.4) | 38 (53.5) | 16 (57.1) | |
| 7 days/week | 1 (5.9) | 7 (9.9) | 35.7 | |
a
Cirrhosis was determined by liver biopsy and/or clinical events including esophageal varices, encephalopathy, or ascites.
b
Two subjects declined HIV testing and therefore their HIV status was unknown.